Trade Summary
1 month ago, Mpm Bioventures 2018, L.P., serving as 10% owner at Aktis Oncology, Inc. (AKTS), purchased 1,112,777 shares at $18.00 per share, for a total transaction value of $20,029,986.00. Following this transaction, Mpm Bioventures 2018, L.P. now holds 10,260,064 shares of AKTS.
This purchase represents a 12.00% increase in Mpm Bioventures 2018, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, January 14, 2026, 2 days after the trade was made.
